SCHEMBL8225875

SCHEMBL8225875

CC(=O)OOS(C)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9510656 0.79 ALDH1A1 (0.37)
SCHEMBL8723917 0.77
SCHEMBL27682052 0.77
SCHEMBL21816739 0.74
SCHEMBL8867805 0.74
SCHEMBL9589440 0.74 ALDH1A1 (0.44)
SCHEMBL11425554 0.70 TSHR (0.36)
SCHEMBL11583645 0.70 ALDH1A1 (0.30)
SCHEMBL27653314 0.70 ALDH1A1 (0.36)
Cyclohexane SCHEMBL29022135 0.70 CA2 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112055712-A Processes and intermediates for preparing therapeutic compounds useful in the treatment of retroviral infections 吉利德科学公司 2020-12-08 CN disclosed
EP-2477989-A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY Taisho Pharmaceutical Co., Ltd. (JP) 2012-07-25 EP disclosed
WO-2011034215-A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-03-24 WO disclosed